Evaluation of the Clinical Outcomes of the Total Knee ps Prosthesis Implanted With the Use of Inertial Sensors (SYMPHO-EM)

March 13, 2024 updated by: Istituto Ortopedico Rizzoli

Evaluation of the Clinical Outcomes of the Total Knee Prosthesis With Posterior Stabilization Implanted With the Use of Inertial Sensors

evaluate the clinical outcome of the implantation of a specific primary TKA model implanted with the aid of inertial sensors for the execution of bone cuts through the administration of questionnaires for the calculation of clinical-functional scores;

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Italia
      • Bologna, Italia, Italy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients candidates to TKA surgery

Description

Inclusion Criteria:

  1. Male and female subjects 50 years of age or older and less than 85 years of age (>50 and <85 years) who are candidates for primary cemented total knee replacement based on physical examination and medical history, including diagnosis of severe knee pain and disability due to at least one of the following causes:

    • to. Primary or secondary osteoarthritis
    • b. Collagen disorders and/or avascular necrosis of femoral condyle
    • c. Moderate valgus, varus or flexion deformities (HKA between ± 10°, flexion contracture <10°) -
  2. Patients consent and able to complete scheduled study procedures and follow-up assessments.
  3. Patients informed about the nature of the study who signed the "informed consent" approved by the ethics committee.

Exclusion Criteria:

  • Simultaneous participation in other studies
  • Patients not capable of understanding and wanting and therefore unable to sign the informed consent
  • Patients who have already undergone hip or ankle arthroplasty, previous osteotomy, with severe axial deformities or suffering from rheumatoid arthritis, diabetes or neuromuscular diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient treated with PS Link Symphoknee prosthesis and Orthokey perseus alignment device
Knee arthroplasty surgery with perseus orthokey alignment device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Society Score
Time Frame: at baseline (day 0)
Two sections, one evaluating the patient's function and one for his clinical conditions, overall score goes from 0 to 100
at baseline (day 0)
Knee Society Score
Time Frame: 6 months
Two sections, one evaluating the patient's function and one for his clinical conditions, overall score goes from 0 to 100
6 months
Knee Society Score
Time Frame: 12 months
Two sections, one evaluating the patient's function and one for his clinical conditions, overall score goes from 0 to 100
12 months
Knee Society Score
Time Frame: 24 months
Two sections, one evaluating the patient's function and one for his clinical conditions, overall score goes from 0 to 100
24 months
Western Ontario and McMaster Universities Arthritis Index
Time Frame: at baseline (day 0)
The test evaluates main aspects of arthritis such as pain, stiffness articulation and functionality. The score goes from 0 to 96
at baseline (day 0)
Western Ontario and McMaster Universities Arthritis Index
Time Frame: 6 months
The test evaluates main aspects of arthritis such as pain, stiffness articulation and functionality. The score goes from 0 to 96
6 months
Western Ontario and McMaster Universities Arthritis Index
Time Frame: 12 months
The test evaluates main aspects of arthritis such as pain, stiffness articulation and functionality. The score goes from 0 to 96
12 months
Western Ontario and McMaster Universities Arthritis Index
Time Frame: 24 months
The test evaluates main aspects of arthritis such as pain, stiffness articulation and functionality. The score goes from 0 to 96
24 months
36-Item Short Form Health Survey
Time Frame: at baseline (day 0)
is a valid and reliable tool for measuring health outcomes in patients with musculoskeletal pain, but its sensitivity to clinical changes in patients with specific disorders may be limited, rated on a scale of 0 to 100, with 0 and 100 being minimum and maximum possible scores.
at baseline (day 0)
36-Item Short Form Health Survey
Time Frame: 6 months
is a valid and reliable tool for measuring health outcomes in patients with musculoskeletal pain, but its sensitivity to clinical changes in patients with specific disorders may be limited, rated on a scale of 0 to 100, with 0 and 100 being minimum and maximum possible scores.
6 months
36-Item Short Form Health Survey
Time Frame: 12 months
is a valid and reliable tool for measuring health outcomes in patients with musculoskeletal pain, but its sensitivity to clinical changes in patients with specific disorders may be limited, rated on a scale of 0 to 100, with 0 and 100 being minimum and maximum possible scores.
12 months
36-Item Short Form Health Survey
Time Frame: 24 months
is a valid and reliable tool for measuring health outcomes in patients with musculoskeletal pain, but its sensitivity to clinical changes in patients with specific disorders may be limited, rated on a scale of 0 to 100, with 0 and 100 being minimum and maximum possible scores.
24 months
Knee injury and Osteoarthritis Outcome Score
Time Frame: at baseline (day 0)
The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). the score goes from 0 to 100
at baseline (day 0)
Knee injury and Osteoarthritis Outcome Score
Time Frame: 6 months
The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). the score goes from 0 to 100
6 months
Knee injury and Osteoarthritis Outcome Score
Time Frame: 12 months
The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). the score goes from 0 to 100
12 months
Knee injury and Osteoarthritis Outcome Score
Time Frame: 24 months
The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). the score goes from 0 to 100
24 months
Forgotten joint score
Time Frame: at baseline (day 0)
a 12-question patient-reported outcomes measure created to measure a patient's awareness of their artificial joint
at baseline (day 0)
Forgotten joint score
Time Frame: 6 months
a 12-question patient-reported outcomes measure created to measure a patient's awareness of their artificial joint
6 months
Forgotten joint score
Time Frame: 12 months
a 12-question patient-reported outcomes measure created to measure a patient's awareness of their artificial joint
12 months
Forgotten joint score
Time Frame: 24 months
a 12-question patient-reported outcomes measure created to measure a patient's awareness of their artificial joint
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic evaluation of prosthetic femoral component positioning
Time Frame: 5 days after index surgery
measurement of prosthetic femoral component alignment according to femoral mechanical axis
5 days after index surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 13, 2023

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

January 13, 2024

First Submitted That Met QC Criteria

March 13, 2024

First Posted (Actual)

March 20, 2024

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 13, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SYMPHO-EM

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prosthesis Durability

Clinical Trials on Knee arthroplasty

3
Subscribe